Table S5. Correlations between mast cell number and clinic pathological features of patients with gastric cancer. (DOCX 21 kb
Table S5. Differentially expressed genes representing specific immune cell populations across all th...
Additional file 5: Figure S2. TICs with differential profiles between cluster1 and cluster2. (a) Mac...
Figure S1. Gastric cancer cell-derived conditioned medium induced pro-inflammatory factor gene expre...
Table S4. Correlations between mast cell percentage and clinic pathological features of patients wit...
Table S2. Clinical characteristics of 114 patients with gastric cancer. (DOCX 19 kb
Figure S7. Kaplan-Meier plots for disease-free survival by median mast cell percentage (9.315%) or m...
Figure S1. Mast cell percentage (a) or mast cell number (b) and its potential correlations with clin...
Figure S3. Tumor-derived factor TNF-α induces mast cells to express PD-L1. (a) Expression of 2B4, gl...
Figure S4. Tumor-derived TNF-α activates NF-κB pathway to induce PD-L1 expression on mast cells. (a)...
Figure S2. CXCL12-CXCR4 chemotaxis mediates mast cell migration and accumulation in GC tumors. (a) E...
Figure S5. Tumor-infiltrating and tumor-conditioned mast cells suppress T cell immunity through PD-L...
Figure S6. Blockade of mast cell-associated PD-L1 on T cell immunity inhibits tumor growth and GC pr...
Table S1. Association between CD8+ T cells infiltration and patient characteristics. (DOC 64 kb
Abstract Background Mast cells are prominent components of solid tumors and exhibit distinct phenoty...
Table S1. The genes with highest co-expression correlation with IL-6 in TCGA gastric cancer dataset....
Table S5. Differentially expressed genes representing specific immune cell populations across all th...
Additional file 5: Figure S2. TICs with differential profiles between cluster1 and cluster2. (a) Mac...
Figure S1. Gastric cancer cell-derived conditioned medium induced pro-inflammatory factor gene expre...
Table S4. Correlations between mast cell percentage and clinic pathological features of patients wit...
Table S2. Clinical characteristics of 114 patients with gastric cancer. (DOCX 19 kb
Figure S7. Kaplan-Meier plots for disease-free survival by median mast cell percentage (9.315%) or m...
Figure S1. Mast cell percentage (a) or mast cell number (b) and its potential correlations with clin...
Figure S3. Tumor-derived factor TNF-α induces mast cells to express PD-L1. (a) Expression of 2B4, gl...
Figure S4. Tumor-derived TNF-α activates NF-κB pathway to induce PD-L1 expression on mast cells. (a)...
Figure S2. CXCL12-CXCR4 chemotaxis mediates mast cell migration and accumulation in GC tumors. (a) E...
Figure S5. Tumor-infiltrating and tumor-conditioned mast cells suppress T cell immunity through PD-L...
Figure S6. Blockade of mast cell-associated PD-L1 on T cell immunity inhibits tumor growth and GC pr...
Table S1. Association between CD8+ T cells infiltration and patient characteristics. (DOC 64 kb
Abstract Background Mast cells are prominent components of solid tumors and exhibit distinct phenoty...
Table S1. The genes with highest co-expression correlation with IL-6 in TCGA gastric cancer dataset....
Table S5. Differentially expressed genes representing specific immune cell populations across all th...
Additional file 5: Figure S2. TICs with differential profiles between cluster1 and cluster2. (a) Mac...
Figure S1. Gastric cancer cell-derived conditioned medium induced pro-inflammatory factor gene expre...